Pipeline

KD Biopharma has different projects under assessment and is currently in the process of conducting Phase III of an orphan Drug named Alfa® indicated for the treatment of Familial Adenomatous Polyposis (FAP)

Alfa® has also shown to effectively help Ulcerative Colitis (UC) and Sporadic Polyps (SP) patients to keep the disease under control.